Sun Pharmaceutical Industries Inc recalls Mesalamine Extended-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: Out of specification for dissolution.
- Products
-
- Mesalamine Extended-Release Capsules
- Where it was sold
-
Nationwide in the U.S.
Nationwide
- Units affected
- 54,960 bottles
- About this recall
- Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.